The research for efficacy of troponin T in evaluating the severity of fulminant myocarditis
-
摘要: 本研究探索肌钙蛋白T(cTnT)对暴发性心肌炎病情评估的效能。通过回顾性分析2013年1月—2021年5月我院暴发性心肌炎患儿cTnT水平诊断不同病情严重程度的ROC曲线,根据约登指数计算其对病情严重程度评估最佳的界值,分析以界值分组的两组间患儿病情严重程度。最终82例患儿纳入研究,男42例,女40例; 年龄(4.97±4.66)岁; cTnT水平为1.32(0.25,4.94) ng/mL,发生死亡9例,ECMO治疗7例,撤机后存活5例,临时起搏治疗14例,未经ECMO治疗存活的病例68例,cTnT诊断死亡和需ECMO治疗的高危患儿AUC为0.84(0.73,0.96) ng/mL,诊断发生室性心动过速的AUC为0.79(0.61,0.95),诊断高度房室传导阻滞的AUC为0.74(0.64,0.85); cTnT在临界值为1.0 ng/mL时预测高危组和低危组的灵敏度和特异度分别为92.31%和55.07%,cTnT≥1.0 ng/mL的患儿有更高的脏器功能损伤水平和恶性心律失常发生率(P< 0.05)。多因素logistic回归分析结果表明cTnT≥1.0 ng/mL是高危组的危险因素。cTnT≥1.0 ng/mL时,提示患儿有高危的可能,需评估及时转运至有行ECMO治疗条件医院。Abstract: The efficacy of troponin T in evaluating the severity of fulminant myocarditis is explored.Through retrospective analysis of the ROC curve of different disease severity diagnosed by troponin T level in children with fulminant myocarditis in our hospital from January 2013 to may 2021, the best cut-off value of disease severity was calculated according to Youden index, and the disease severity between the two groups grouped by bounds was analyzed. Eighty-two children with fulminant myocarditis were included in the study, including 42 males and 40 females, aged (4.97±4.66) years old; cTnT level was 1.32(0.25, 4.94) ng/mL, 9 cases died, 7 cases were treated with ECMO, and 5 cases survived after removing the machine, 14 cases were treated with temporary pacing therapy, 68 cases survived without ECMO treatment, the AUC of high-risk children diagnosed with cTnT and requiring ECMO treatment was 0.84(0.73, 0.96), and the AUC for the diagnosis of ventricular tachycardia was 0.79(0.61, 0.95), the AUC for the diagnosis of high-grade atrioventricular block was 0.74(0.64, 0.85). When the cut-off value was 1.0 ng/mL, the sensitivity and specificity of predicting the high-risk group and the low-risk group were 92.31% and 55.07% respectively, children with cTnT higher than 1.00 had a higher level of organ damage and the incidence of malignant arrhythmia(P< 0.05). Multivariate Logistic regression analysis showed that cTnT≥1.0 ng/mL was a risk factor for high risk group. When the cTnT≥1.0 ng/mL, it indicates that children have a higher risk. It is necessary to evaluate and transfer them to a hospital with ECMO treatment conditions in a timely manner.
-
Key words:
- troponin T /
- acute fulminant myocarditis /
- children /
- ECMO
-
-
表 1 cTnT对高危和低危患儿诊断最佳界值分析
界值/(ng·mL-1) 灵敏度/% 特异度/% 阳性预测值/% 阴性预测值/% 约登指数 0.5 100 40.58 24.07 100 0.41 1.0 92.31 55.07 27.91 97.44 0.47 1.5 84.62 62.32 29.73 95.56 0.46 表 2 最佳界值分组的两组间患儿病情严重程度的比较
X±S,M(P25,P75) 指标 cTnT≥1.0 ng/mL组(43例) cTnT < 1.0 ng/mL组(39例) Z/χ2 P 肌酸激酶/(U·L-1) 1029.16±804.98 424.55±795.08 5.21 0.00 肌酸激酶同工酶/(U·L-1) 83.35±76.40 68.76±103.69 2.98 0.00 乳酸水平/(mmol·L-1) 5.66±4.41 3.64±4.02 3.10 0.00 肌酐/(μmol·L-1) 69.63±45.51 35.87±18.14 4.90 0.00 尿素氮/(mmol·L-1) 8.74±5.38 5.83±2.56 2.81 0.00 谷草转氨酶/(IU·L-1) 212.80(86.20,383.40) 59.00(43.0,188.0) 4.05 0.00 血糖/(mmol·L-1) 7.01±2.77 5.86±2.06 2.16 0.03 NT-proBNP/(pg·mL-1) 21481.35±7056.17 18748.95±9607.03 1.37 0.17 存在恶性心律失常/例 32/43 7/39 26.15 0.00 表 3 多种实验室指标与是否高危的多因素logistic回归分析
实验室指标 B 标准误差 瓦尔德 显著性 Exp(B) 95%CI 乳酸 4.25 1.26 11.48 0.00 70.35 6.01~823.58 NT-proBNP 2.47 1.43 2.98 0.08 11.80 0.72~194.53 肌酸激酶 2.50 1.17 4.55 0.03 12.23 1.22~122.17 肌酸激酶同工酶 1.12 0.91 1.54 0.22 3.08 0.52~18.15 谷草转氨酶 -2.09 1.07 3.80 0.05 0.13 0.02~1.01 cTnT 3.09 1.16 7.04 0.01 21.94 2.24~214.72 常量 -8.59 2.32 13.75 0.00 0.00 -
[1] Ginsberg F, Parrillo JE. Fulminant myocarditis[J]. Crit Care Clin, 2013, 29(3): 465-483.
[2] 褚志祥, 王猛, 朱海燕. 爆发性心肌炎的诊治进展[J]. 临床急诊杂志, 2019, 20(9): 687-691. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZLC201909006.htm
[3] 中华医学会心血管病学分会精准医学学组, 中华心血管病杂志编辑委员会, 成人暴发性心肌炎工作组. 成人暴发性心肌炎诊断与治疗中国专家共识[J]. 内科急危重症杂志, 2017, 23(6): 443-453. https://www.cnki.com.cn/Article/CJFDTOTAL-NKJW201706002.htm
[4] 黄敏, 沈捷, 陈秀玉, 等. 上海地区小儿暴发型心肌炎50例临床分析[J]. 临床儿科杂志, 2007, 25(2): 113-115. doi: 10.3969/j.issn.1000-3606.2007.02.011
[5] Kociol RD, Cooper LT, Fang JC, et al. Recognition and Initial Management of Fulminant Myocarditis: A Scientific Statement From the American Heart Association[J]. Circulation, 2020, 141(6): e69-e92.
[6] 陈容欣, 史婧奕, 任玉倩, 等. 体外膜氧合救治儿童爆发性心肌炎的临床疗效观察[J]. 中华医学杂志, 2019, 99(47): 3715-3719. doi: 10.3760/cma.j.issn.0376-2491.2019.47.008
[7] 中国医师协会体外生命支持专业委员会儿科学组, 中国医师协会儿童重症医师分会体外生命支持委员会, 中华医学会儿科分会急救学组, 等. 体外膜氧合支持儿科暴发性心肌炎专家共识[J]. 中华急诊医学杂志, 2020, 29(1): 36-42. doi: 10.3760/cma.j.issn.1671-0282.2020.01.005
[8] Heinsar S, Raman S, Suen JY, et al. The use of extracorporeal membrane oxygenation in children with acute fulminant myocarditis[J]. Clin Exp Pediatr, 2021, 64(5): 188-195. doi: 10.3345/cep.2020.00836
[9] 张成磊, 祝茜, 张永华, 等. 探讨高敏肌钙蛋白Ⅰ联合常规心肌标志物对微小心肌损伤的诊断价值[J]. 中国卫生检验杂志, 2016, 26(21): 3143-3146. https://www.cnki.com.cn/Article/CJFDTOTAL-ZWJZ201621034.htm
[10] 马丽娟. 心肌损伤标志物在儿童心肌损伤性疾病诊断中的临床价值评估[J]. 中华检验医学杂志, 2015, (6): 370-372. doi: 10.3760/cma.j.issn.1009-9158.2015.06.004
[11] Ukena C, Kindermann M, Mahfoud F, et al. Diagnostic and prognostic validity of different biomarkers in patients with suspected myocarditis[J]. Clin Res Cardiol, 2014, 103(9): 743-751. doi: 10.1007/s00392-014-0709-z
[12] 田杰, 朱静, 张渝美, 等. 血清心脏肌钙蛋白I对小儿病毒性心肌炎诊断和转归监测价值[J]. 中国当代儿科杂志, 2001, 3(5): 506-508. doi: 10.3969/j.issn.1008-8830.2001.05.006
[13] 易聪, 佘香, 易岂建. 222例儿童病毒性心肌炎临床分析[J]. 重庆医科大学学报, 2020, 45(4): 459-463. https://www.cnki.com.cn/Article/CJFDTOTAL-ZQYK202004007.htm
[14] 张刚, 陈旭锋, 张劲松, 等. 24 h肌钙蛋白T下降率对ECMO治疗的急性暴发性心肌炎患者预后的影响[J]. 中华急诊医学杂志, 2020, 29(2): 217-221. https://www.cnki.com.cn/Article/CJFDTOTAL-ZRZX202108012.htm
[15] Yu SR, Zhang CY, Xiong WJ, et al. An Hypothesis: Disproportion Between Cardiac Troponin and B-Type Natriuretic Peptide Levels-A High Risk and Poor Prognostic Biomarker in Patients With Fulminant Myocarditis?[J]. Heart Lung Circ, 2021, 30(6): 837-842.
[16] 盛楚乔, 张圳, 李玉梅, 等. 连续性血液净化治疗儿童暴发性心肌炎疗效观察[J]. 中国当代儿科杂志, 2015, 17(6): 638-641. https://www.cnki.com.cn/Article/CJFDTOTAL-DDKZ201506024.htm
[17] 严凤娣, 吴晓燕, 殷静静, 等. 体外膜肺氧合治疗急性暴发性心肌炎合并心源性休克16例临床分析[J]. 临床急诊杂志, 2021, 22(8): 521-525. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZLC202108002.htm
[18] 楼咪丽, 徐卫兰. 病毒性心肌炎患儿心肌酶、肌钙蛋白Ⅰ和心电图检测及意义[J]. 中国卫生检验杂志, 2020, 30(1): 81-82, 86. https://www.cnki.com.cn/Article/CJFDTOTAL-ZWJZ202001027.htm
-